Insider Trading & Ownership - Skvarka Jan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Skvarka Jan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-11
Sale
2023-09-13
4:11 pm
Zentalis Pharmaceuticals Inc.ZNTLSkvarka Jan
Director
5,000$25.05$125,23847,970
(Direct)
View
2021-05-11
Sale
2021-05-13
4:12 pm
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
130,500$9.2083$1,201,6831,580,302
(Direct)
View
2021-01-13
Sale
2021-01-15
4:19 pm
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
25,000$15.03$375,7872,519,581
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-21
Option Award
2024-06-21
5:11 pm
N/A
N/A
Zentalis Pharmaceuticals Inc.ZNTLSkvarka Jan
Director
41,581$089,551
(Direct)
View
2024-06-12
Option Award
2024-06-13
4:30 pm
N/A
2034-06-12
Monte Rosa Therapeutics Inc.GLUESkvarka Jan
Director
22,100$022,100
(Direct)
View
2023-06-16
Option Award
2023-06-16
5:01 pm
N/A
N/A
Zentalis Pharmaceuticals Inc.ZNTLSkvarka Jan
Director
16,364$052,970
(Direct)
View
2023-06-14
Option Award
2023-06-15
4:29 pm
N/A
2033-06-13
Monte Rosa Therapeutics Inc.GLUESkvarka Jan
Director
20,500$020,500
(Direct)
View
2023-03-30
Option Award
2023-03-31
4:15 pm
N/A
2033-03-29
Monte Rosa Therapeutics Inc.GLUESkvarka Jan
Director
41,000$041,000
(Direct)
View
2022-09-09
Option Award
2022-09-12
07:07 am
N/A
N/A
Zentalis Pharmaceuticals Inc.ZNTLSkvarka Jan
Director
36,606$036,606
(Direct)
View
2021-11-17
Disposition
2021-11-19
1:20 pm
N/A
2029-11-07
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
1,959,500$00
(Direct)
View
2021-05-11
Exercise
2021-05-13
4:12 pm
N/A
N/A
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
43,000$0.3141,580,302
(Direct)
View
2021-05-11
Exercise
2021-05-13
4:12 pm
N/A
N/A
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
87,500$0.44621,580,302
(Direct)
View
2021-05-11
Exercise
2021-05-13
4:12 pm
N/A
2029-09-25
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
130,500$01,580,302
(Direct)
View
2021-01-13
Exercise
2021-01-15
4:19 pm
N/A
N/A
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
5,419$0.42482,519,581
(Direct)
View
2021-01-14
Exercise
2021-01-15
4:19 pm
N/A
N/A
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
19,581$0.42752,519,581
(Direct)
View
2021-01-13
Exercise
2021-01-15
4:19 pm
N/A
2029-09-25
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
25,000$02,519,581
(Direct)
View

Ownership
2021-01-04
8:11 pm
N/A
2030-12-23
Trillium Therapeutics Inc.TRILSkvarka Jan
President and CEO
0$02,115,000
(Direct)
View